GEN Pharmaceuticals has received ethical approval from an accredited medical research ethics committee in the Netherlands to conduct a small clinical trial testing SUL-238, its investigational medication for Parkinson’s disease. With this approval, the company will activate a clinical site in Groningen in the northern Netherlands with patient…
